RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT's ticker is and the CUSIP is H6759S100. A total of 4 filers reported holding RELIEF THERAPEUTICS HOLDING AG NAMEN-AKT in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -81.0% | 132,000 | -7.0% | 0.00% | -100.0% |
| Q3 2021 | $21,000 | -25.0% | 142,000 | +13.6% | 0.00% | -33.3% |
| Q2 2021 | $28,000 | -26.3% | 125,000 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $38,000 | -19.1% | 125,000 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $47,000 | – | 125,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 175,000 | $38,000 | 0.01% |
| Stonebridge Financial Planning Group, LLC | 45,780 | $9,000 | 0.01% |
| HighPoint Advisor Group LLC | 125,000 | $28,000 | 0.00% |
| Ancora Advisors LLC | 150,000 | $32,000 | 0.00% |
| Steward Partners Investment Advisory, LLC | 156,064 | $34,000 | 0.00% |
| SVB WEALTH LLC | 140,000 | $31,000 | 0.00% |